FYERS
Home
/
Stocks
/
Balance Sheet
/
Glenmark Pharmaceuticals Balance Sheet

Glenmark Pharmaceuticals Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)2,405.00
Volume (₹)3.05 L
High (₹)2,461.10
Upper Circuit2,648.80
Low (₹)2,380.10
Lower Circuit2,167.20
Prev Close2,408.00
52W High (₹)2,537.60
Price2,455.80
52W Low (₹)1,801.40

Share Market Cap & Key Ratios Overview

M.Cap (₹)67875.00 Cr
Div. Yield (%)0.10
PE Ratio37.75
Debt to Equity0.00
Price to Book5.75
Book Value371.30
EPS (TTM)63.70
Face Value1.00
ROE (%)14.10

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
GLENMARKNSE
LTP
1W Low
1W High
Market cap (₹)
1787.3+9.6 (0.54%)
1722
1810.40
4,25,150Cr
10023.5+243.5 (2.49%)
9863
10067
2,66,265Cr
4667.4+54 (1.17%)
4553
4685.60
1,76,301Cr
2333.7-71.8 (-2.98%)
2252.40
2441.90
1,25,352Cr
1257.5+12 (0.96%)
1217.20
1266.60
1,23,591Cr
1368.4+16.4 (1.21%)
1336.70
1376.70
1,14,351Cr
1396+17.1 (1.24%)
1364.60
1400.80
1,12,474Cr
2487.6-5.2 (-0.21%)
2457.90
2512.30
1,02,315Cr
1703.7+22.3 (1.33%)
1656.20
1713.80
97,757Cr
2040.5+29.5 (1.47%)
1988.90
2062.10
92,007Cr
2455.8+157.1 (6.83%)
2306
2461.10
67,875Cr

Key Highlights of Glenmark Pharmaceuticals Ltd Balance Sheet

Glenmark Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹28.22Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹28.22Cr, and the reserves and surplus of the company is ₹24117Cr.

The company has its non-current liabilities with total liabilities of ₹34216.1Cr as of 2026-03-31.

The current liabilities are ₹3669.03Cr as of 2026-03-31. At the same time, current assets are ₹6095.1Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹15202.2Cr and tangible assets of ₹2027.9Cr, provided in the Glenmark Pharmaceuticals Ltd financial statements.